UCLA/Caltech team uncovers a new and simple way to learn the structures of small molecules
In a new study that one scientist called jaw-dropping, a joint UCLA/Caltech team has shown that it is possible to obtain the structures of small molecules, such as certain hormones and medications, in as little as 30 minutes. That’s hours and even days less than was possible before.
The team used a technique called micro-electron diffraction (MicroED), which had been used in the past to learn the 3-D structures of larger molecules, specifically proteins. In this new study, the researchers show that the technique can be applied to small molecules, and that the process requires much less preparation time than expected. Unlike related techniques—some of which involve growing crystals the size of salt grains—this method, as the new study demonstrates, can work with run-of-the-mill starting samples, sometimes even powders scraped from the side of a beaker.
“We took the lowest-brow samples you can get and obtained the highest-quality structures in barely any time,” says Caltech professor of chemistry Brian Stoltz, who is a co-author on the new study, published in the journal ACS Central Science. “When I first saw the results, my jaw hit the floor.” Initially released on the pre-print server Chemrxiv in mid-October, the article has been viewed more than 35,000 times.
The reason the method works so well on small-molecule samples is that while the samples may appear to be simple powders, they actually contain tiny crystals, each roughly a billion times smaller than a speck of dust. Researchers knew about these hidden microcrystals before, but did not realize they could readily reveal the crystals’ molecular structures using MicroED. “I don’t think people realized how common these microcrystals are in the powdery samples,” says Stoltz. “This is like science fiction. I didn’t think this would happen in my lifetime—that you could see structures from powders.”
The results have implications for chemists wishing to determine the structures of small molecules, which are defined as those weighing less than about 900 daltons. (A dalton is about the weight of a hydrogen atom.) These tiny compounds include certain chemicals found in nature, some biological substances like hormones, and a number of therapeutic drugs. Possible applications of the MicroED structure-finding methodology include drug discovery, crime lab analysis, medical testing, and more. For instance, Stoltz says, the method might be of use in testing for the latest performance-enhancing drugs in athletes, where only trace amounts of a chemical may be present.
“The slowest step in making new molecules is determining the structure of the product. That may no longer be the case, as this technique promises to revolutionize organic chemistry,” says Robert Grubbs, Caltech’s Victor and Elizabeth Atkins Professor of Chemistry and a winner of the 2005 Nobel Prize in Chemistry, who was not involved in the research. “The last big break in structure determination before this was nuclear magnetic resonance spectroscopy, which was introduced by Jack Roberts at Caltech in the late ’60s.”
Like other synthetic chemists, Stoltz and his team spend their time trying to figure out how to assemble chemicals in the lab from basic starting materials. Their lab focuses on such natural small molecules as the fungus-derived beta-lactam family of compounds, which are related to penicillins. To build these chemicals, they need to determine the structures of the molecules in their reactions—both the intermediate molecules and the final products—to see if they are on the right track.
One technique for doing so is X-ray crystallography, in which a chemical sample is hit with X-rays that diffract off its atoms; the pattern of those diffracting X-rays reveals the 3-D structure of the targeted chemical. Often, this method is used to solve the structures of really big molecules, such as complex membrane proteins, but it can also be applied to small molecules. The challenge is that to perform this method a chemist must create good-sized chunks of crystal from a sample, which isn’t always easy. “I spent months once trying to get the right crystals for one of my samples,” says Stoltz.
Another reliable method is NMR (nuclear magnetic resonance), which doesn’t require crystals but does require a relatively large amount of a sample, which can be hard to amass. Also, NMR provides only indirect structural information.
Before now, MicroED—which is similar to X-ray crystallography but uses electrons instead of X-rays—was mainly used on crystallized proteins and not on small molecules. Co-author Tamir Gonen, an electron crystallography expert at UCLA who began developing the MicroED technique for proteins while at the Howard Hughes Medical Institute in Virginia, said that he only started thinking about using the method on small molecules after moving to UCLA and teaming up with Caltech.
“Tamir had been using this technique on proteins, and just happened to mention that they can sometimes get it to work using only powdery samples of proteins,” says Hosea Nelson (PhD ’13), an assistant professor of chemistry and biochemistry at UCLA. “My mind was blown by this, that you didn’t have to grow crystals, and that’s around the time that the team started to realize that we could apply this method to a whole new class of molecules with wide-reaching implications for all types of chemistry.”
The team tested several samples of varying qualities, without ever attempting to crystallize them, and were able to determine their structures thanks to the samples’ ample microcrystals. They succeeded in getting structures for ground-up samples of the brand-name drugs Tylenol and Advil, and they were able to identify distinct structures from a powdered mixture of four chemicals.
The UCLA/Caltech team says it hopes this method will become routine in chemistry labs in the future.
“In our labs, we have students and postdocs making totally new and unique molecular entities every day,” says Stoltz. “Now we have the power to rapidly figure out what they are. This is going to change synthetic chemistry.”
Learn more: From Beaker to Solved 3-D Structure in Minutes
The Latest on: Small molecules
via Google News
The Latest on: Small molecules
- Small molecules could hold the key to enhancing the efficiency of organic solar cellson November 24, 2020 at 6:22 am
Understanding how particles travel through a device is vital for improving the efficiency of solar cells. Researchers from KAUST, working with an international team of scientists, have now developed a ...
- Outlook on the Bio CMO Global Market to 2024 - Preference of Biologics Over Small Molecules is Driving Growthon November 23, 2020 at 2:55 am
Size & Forecasts with Impact Analysis of COVID-19 (2020-2024 Edition)" report has been added to ResearchAndMarkets.com's offering. This report provides an analysis of the global bio CMO market, with ...
- Sosei Heptares' COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Developmenton November 20, 2020 at 1:25 am
PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) announces a progress update for its R&D program focused on the design and development of novel drugs targeting the SARS-CoV-2 ...
- Raman microscopy-based approach uses gold nanoparticles for visualizing small-molecule drugson November 19, 2020 at 9:36 pm
Successful drug development has a significant impact on people's quality of life worldwide. Being able to track how molecules get into target cells, and observing what they do when they are inside, is ...
- Scattering of adiabatically aligned molecules by non-resonant optical standing waveson November 19, 2020 at 7:37 am
A research team, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has discovered that when the rotational quantum states of non-polar molecules change under the ...
- Lead Pharma enters into a Research Collaboration a…on November 19, 2020 at 5:52 am
Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases R&D collaboration building on Lead Pharma’s expertise in ...
- New Microscopy Approach to Observe Dynamics of Small-Molecule Drugs in Cellson November 19, 2020 at 5:45 am
The quality of life of people around the world has been considerably influenced by successful drug development.
- Lead Pharma collaborates with Roche to develop oral small molecules to treat immune mediated diseaseson November 16, 2020 at 9:30 pm
Lead Pharma, a clinical stage pharmaceutical company, announced that it has entered into a collaboration and license agreement with Roche to develop oral small molecules to treat a broad range of ...
- Roche, Lead Pharma partner to develop oral small molecules for immune-mediated diseaseson November 16, 2020 at 4:11 am
Lead Pharma inked a collaboration and license agreement with Roche for the development of oral small molecules to treat a range of immune-mediated diseases.
via Bing News